Liposomes as carriers for colchicine-derived prodrugs: Vascular disrupting nanomedicines with tailorable drug release kinetics

European Journal of Pharmaceutical Sciences

Volumn 45, Issue 4, 2012, Pages 429-435

  Crielaard, Bart J ^a   Van Der Wal, Steffen ^a   Le, Huong Thu ^a   Bode, Aloïs T L ^a   Lammers, Twan ^a   Hennink, Wim E ^a   Schiffelers, Raymond M ^a   Fens, Marcel H A M ^a   Storm, Gert ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cancer; Colchicine; Colchicinoids; Liposomes; Prodrugs; Vascular disrupting agents

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [METHOXY(POLYETHYLENE GLYCOL) 2000]; COLCHICINE; COLCHICINE DERIVATIVE; COLCHICINOID DERIVATIVE; DEACETYLCOLCHICINE; LIPOSOME; MACROGOL 2000; MPEG ACETYL N (2 HYDROXYACETYL)DEACETYLCOLCHICINE ESTER; MPEG PROPIONYL N (2 HYDROXYPROPIONYL)DEACETYLCOLCHICINE ESTER; N (2 HYDROXYACETYL)DEACETYLCOLCHICINE; N (2 HYDROXYPROPIONYL)DEACETYLCOLCHICINE; N BOC DEACETYLCOLCHICINE; PRODRUG; UNCLASSIFIED DRUG; VASCULAR TARGETING AGENT;

CONFERENCE PAPER; DRUG DEGRADATION; DRUG RELEASE; DRUG STRUCTURE; DRUG SYNTHESIS; PH MEASUREMENT; PRIORITY JOURNAL; TEMPERATURE MEASUREMENT;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; ANGIOGENESIS INHIBITORS; CHOLESTEROL; COLCHICINE; HYDROLYSIS; KINETICS; LIPOSOMES; NANOMEDICINE; PHOSPHATIDYLETHANOLAMINES; POLYETHYLENE GLYCOLS; PRODRUGS; TUBULIN MODULATORS;

EID: 84856268320     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2011.08.027     Document Type: Conference Paper

References (37)

1. J.D. Bagnato, A.L. Eilers, R.A. Horton, and C.B. Grissom Synthesis and characterization of a cobalamin-colchicine conjugate as a novel tumor-targeted cytotoxin J. Org. Chem. 69 2004 8987 8996 (Pubitemid 40004017)
2. B.C. Baguley, K.M. Holdaway, L.L. Thomsen, L. Zhuang, and L.J. Zwi Inhibition of growth of colon 38 adenocarcinoma by vinblastine and colchicine: evidence for a vascular mechanism Eur. J. Cancer 27 1991 482 487
3. P. Baluk, H. Hashizume, and D.M. McDonald Cellular abnormalities of blood vessels as targets in cancer Curr. Opin. Genet. Dev. 15 2005 102 111 (Pubitemid 40127638)
4. S.J. Bell, C.M. Fam, E.A. Chlipala, S.J. Carlson, J.I. Lee, M.S. Rosendahl, D.H. Doherty, and G.N. Cox Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-α protein therapeutic Bioconjug. Chem. 19 2007 299 305 (Pubitemid 351213862)
5. B. Bhattacharyya, D. Panda, S. Gupta, and M. Banerjee Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin Med. Res. Rev. 28 2008 155 183 (Pubitemid 350274963)
6. R. Bibas, N.K. Gaspar, and M. Ramos-e-Silva Colchicine for dermatologic diseases J. Drugs Dermatol. 4 2005 196 204
7. K. Bombuwala, T. Kinstle, V. Popik, S.O. Uppal, J.B. Olesen, J. Vina, and C.A. Heckman Colchitaxel, a coupled compound made from microtubule inhibitors colchicine and paclitaxel Beilstein J. Org. Chem. 2 2006 13
8. A. Brossi, P.N. Sharma, L. Atwell, A.E. Jacobson, M.A. Iorio, M. Molinari, and C.F. Chignell Biological effects of modified colchicines. 2. Evaluation of catecholic colchicines, colchifolines, colchicide, and novel N-acyl- and N-aroyldeacetyl-colchicines J. Med. Chem. 26 1983 1365 1369 (Pubitemid 13020888)
9. P. Carmeliet, and R.K. Jain Angiogenesis in cancer and other diseases Nature 407 2000 249 257
10. C. Cerquaglia, M. Diaco, G. Nucera, M. La Regina, M. Montalto, and R. Manna Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update Curr. Drug Targets Inflamm. Allergy 4 2005 117 124 (Pubitemid 40584862)
11. M. Coimbra, B. Isacchi, L. van Bloois, J.S. Torano, A. Ket, X. Wu, F. Broere, J.M. Metselaar, C.J.F. Rijcken, G. Storm, R. Bilia, and R.M. Schiffelers Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes Int. J. Pharm. 416 2011 433 442
12. D.B. Fenske, and P.R. Cullis Liposomal nanomedicines Expert. Opin. Drug. Deliv. 5 2008 25 44 (Pubitemid 351234108)
13. M.A. Iorio, M. Molinari, and A. Brossi Synthesis of colchifoline from deacetyl-colchiceine Can. J. Chem. 59 1981 283 284
14. M.A. Jordan, and L. Wilson Microtubules as a target for anticancer drugs Nat. Rev. Cancer 4 2004 253 265 (Pubitemid 38525281)
15. C. Kanthou, and G.M. Tozer Tumour targeting by microtubule-depolymerizing vascular disrupting agents Expert Opin Ther Targets 11 2007 1443 1457 (Pubitemid 350200480)
16. M.P. Keith, and W.R. Gilliland Updates in the management of gout Am. J. Med. 120 2007 221 224 (Pubitemid 46341155)
17. S.B. Kulkarni, M. Singh, and G.V. Betageri Encapsulation, stability and in-vitro release characteristics of liposomal formulations of colchicine J. Pharm. Pharmacol. 49 1997 491 495 (Pubitemid 27229470)
18. D. Lagnoux, T. Darbre, M.L. Schmitz, and J.L. Reymond Inhibition of mitosis by glycopeptide dendrimer conjugates of colchicine Chem. Eur. J. 11 2005 3941 3950 (Pubitemid 40891173)
19. T. Lammers, W.E. Hennink, and G. Storm Tumour-targeted nanomedicines: principles and practice Br. J. Cancer 99 2008 392 397
20. Lippert, J.W., 3rd, 2007. Vascular disrupting agents. Biorg. Med. Chem. 15, 605-615.
21. S. Mons, F. Veretout, M.F. Carlier, I. Erk, J. Lepault, E. Trudel, C. Salesse, P. Ducray, C. Mioskowski, and L. Lebeau The interaction between lipid derivatives of colchicine and tubulin: Consequences of the interaction of the alkaloid with lipid membranes BBA-Biomembranes 1468 2000 381 395
22. T.L. Nguyen, C. McGrath, A.R. Hermone, J.C. Burnett, D.W. Zaharevitz, B.W. Day, P. Wipf, E. Hamel, and R. Gussio A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach J. Med. Chem. 48 2005 6107 6116 (Pubitemid 41324618)
23. Y. Nihei, M. Suzuki, A. Okano, T. Tsuji, Y. Akiyama, T. Tsuruo, S. Saito, K. Hori, and Y. Sato Evaluation of antivascular and antimitotic effects of tubulin binding agents in solid tumor therapy Jpn. J. Cancer Res. 90 1999 1387 1395 (Pubitemid 30032079)
24. S. Parveen, and S.K. Sahoo Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs Clin. Pharmacokinet. 45 2006 965 988 (Pubitemid 44436001)
25. E. Pasquier, S. Honore, and D. Braguer Microtubule-targeting agents in angiogenesis: where do we stand? Drug Resist. Update 9 2006 74 86 (Pubitemid 43928807)
26. E. Pasquier, and M. Kavallaris Microtubules: a dynamic target in cancer therapy IUBMB Life 60 2008 165 170
27. D. Petersel, and N. Schlesinger Treatment of acute gout in hospitalized patients J. Rheumatol. 34 2007 1566 1568 (Pubitemid 47067996)
28. F.R. Quinn, Z. Neiman, and J.A. Beisler Toxicity and quantitative structure-activity relationships of colchicines J. Med. Chem. 24 1981 636 639 (Pubitemid 11021907)
29. J. Rautio, H. Kumpulainen, T. Heimbach, R. Oliyai, D. Oh, T. Jarvinen, and J. Savolainen Prodrugs: design and clinical applications Nat. Rev. Drug Discov. 7 2008 255 270 (Pubitemid 351324639)
30. R.B.G. Ravelli, B. Gigant, P.A. Curmi, I. Jourdain, S. Lachkar, A. Sobel, and M. Knossow Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain Nature 428 2004 198 202 (Pubitemid 38374318)
31. M.J. Roberts, M.D. Bentley, and J.M. Harris Chemistry for peptide and protein PEGylation Adv. Drug Deliv. Rev. 54 2002 459 476 (Pubitemid 34615543)
32. P.N. Sharma, A. Brossi, J.V. Silverton, and C.F. Chignell Synthesis and binding to tubulin of colchicine spin probes J. Med. Chem. 27 1984 1729 1733 (Pubitemid 15177922)
33. R.A. Terkeltaub Colchicine update: 2008 Semin. Arthritis Rheum. 38 2009 411 419
34. P.E. Thorpe Vascular targeting agents as cancer therapeutics Clin. Cancer Res. 10 2004 415 427 (Pubitemid 38173977)
35. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160 (Pubitemid 40282557)
36. G.M. Tozer, C. Kanthou, and B.C. Baguley Disrupting tumour blood vessels Nat. Rev. Cancer 5 2005 423 435 (Pubitemid 40791485)
37. J.M. Zamora, H.L. Pearce, and W.T. Beck Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells Mol. Pharmacol. 33 1988 454 462